# A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

> **NCT05741385** · NA · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 4 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Caffeine
- **DRUG:** Warfarin sodium
- **DRUG:** Omeprazole
- **DRUG:** Metoprolol
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT05741385
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-10
- **Primary completion:** 2024-08-09
- **Final completion:** 2024-08-23
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05741385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05741385, "A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05741385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*